NanoViricides(NNVC)

Search documents
NanoViricides exploring emergency protocol to evaluate NV-387 for MPOX
Proactiveinvestors NA· 2024-08-26 12:51
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387
Proactiveinvestors NA· 2024-08-19 12:48
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. S ...
NanoViricides reports major progress in advancing broad-spectrum antiviral drug NV-387
Proactiveinvestors NA· 2024-08-08 12:37
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
Can Nanotechnology offer Better Solutions for COVID, RSV and other Viruses?
Newsfile· 2024-08-02 11:00
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 2, 2024) - Investorideas.com, a go-to investing platform covering biotech and nanotechnology issues a snapshot looking at news and developments in the antiviral market, featuring NanoViricides, Inc. (NYSE American: NNVC), a development stage company that is creating special purpose nanomaterials for antiviral therapy. Read the full article on Investorideas.com https://www.investorideas.com/News/2024/nanotech/08020Better-Solutions-for- ...
NanoViricides' lead asset for broad spectrum efficacy wins praise in industry reports
Proactiveinvestors NA· 2024-08-01 12:46
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides spotlights lead drug candidate's potential as COVID therapy
Proactiveinvestors NA· 2024-07-24 13:09
About this content About the publisher Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. Use of technology Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows. About Emily Jarvie Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable ...
NanoViricides discusses lead program and next steps
Proactiveinvestors NA· 2024-07-11 13:02
Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research Read more Proactive has always been a forward looking and enthusiastic technology adopter. About this content About the publisher Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. The team delivers news and unique insights across the market including but not co ...
NanoViricides hails broad potential of lead antiviral drug as it prepares to begin first Phase II trial
Proactiveinvestors NA· 2024-07-01 14:57
About Oliver Haill Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists. The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies. ...
NanoViricides hails the potential of NV-387 in combatting bird flu virus H5N1
Proactiveinvestors NA· 2024-06-24 12:37
About Ian Lyall About the publisher We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors. Proactive has always been a forward looking and enthusiastic technology adopter. About this content Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive ...
NanoViricides says antiviral drug candidate shows promise in protecting lungs against Influenza A
Proactiveinvestors NA· 2024-06-20 13:38
Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The Canberra Times, and... Read more Abou ...